The OAS1 effect on COVID-19 in Europeans has been well-replicated in previous GWAS and MR studies,21 with our findings also validating the effects of OAS1 on COVID-19 severity via alternative splicing.44 The gene discussed is OAS1; the disease is COVID-19.